21,087 Shares in Colgate-Palmolive (NYSE:CL) Bought by AXQ Capital LP

AXQ Capital LP acquired a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 21,087 shares of the company's stock, valued at approximately $1,917,000. Colgate-Palmolive makes up about 0.9% of AXQ Capital LP's portfolio, making the stock its 5th biggest holding.

Several other hedge funds and other institutional investors have also made changes to their positions in CL. Kohmann Bosshard Financial Services LLC acquired a new position in Colgate-Palmolive in the 4th quarter valued at $26,000. Centricity Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter worth $27,000. Union Bancaire Privee UBP SA purchased a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $32,000. Briaud Financial Planning Inc acquired a new position in Colgate-Palmolive during the fourth quarter worth about $32,000. Finally, Wintrust Investments LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $33,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Trading Up 2.7 %

NYSE CL traded up $2.46 during trading hours on Wednesday, hitting $92.05. The company's stock had a trading volume of 4,700,411 shares, compared to its average volume of 4,238,640. The stock has a fifty day moving average of $89.52 and a 200 day moving average of $93.81. The firm has a market capitalization of $74.70 billion, a P/E ratio of 26.15, a PEG ratio of 4.20 and a beta of 0.40. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30.

Remove Ads

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the company posted $0.87 EPS. Equities research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th will be paid a $0.52 dividend. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $2.08 annualized dividend and a yield of 2.26%. Colgate-Palmolive's dividend payout ratio is currently 56.82%.

Colgate-Palmolive declared that its Board of Directors has approved a share repurchase plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the company to purchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board of directors believes its stock is undervalued.

Wall Street Analyst Weigh In

Several research firms have weighed in on CL. Barclays lowered their target price on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a report on Friday, January 17th. StockNews.com downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Tuesday. Morgan Stanley decreased their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research note on Monday, February 3rd. Stifel Nicolaus decreased their price target on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a report on Monday, February 3rd. Finally, UBS Group cut their target price on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a research report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $101.72.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.